🇺🇸

Index Intelligence

· daily

S&P 500 Consumer Discretionary Sector SEC Filings — August 04, 2026

The S&P 500 Consumer Discretionary sector is showing a clear divergence between resilient travel demand and a softening quick-service restaurant (QSR) environment. Booking Holdings reported a 118% surge in net income and 8% revenue growth, though forward guidance for room night growth points to a deceleration. In contrast, McDonald's U.S. comparable sales growth slowed sharply to +0.8% from +2.5% a year ago, prompting a leadership change. Carvana saw a significant insider buying event from a director ($1.54M) alongside multiple C-suite sales under 10b5-1 plans, creating a mixed signal on management conviction. Capital allocation trends are aggressive: Booking Holdings is deepening its stockholders' deficit through buybacks, while Aptiv used a $1.9B spin-off dividend to aggressively deleverage. The period-over-period data reveals margin expansion at Aptiv (+160 bps) and strong earnings growth at Booking, but the overall consumer discretionary landscape is cautious, with negative guest counts at McDonald's and mixed insider activity across the portfolio.

16 high priority 4 medium 20 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — August 04, 2026

The S&P 500 Healthcare sector is exhibiting a clear bifurcation in Q2 2026: top-tier innovators like Vertex and Amgen are delivering double-digit revenue growth (12.5% and 10% YoY, respectively) and expanding margins, while legacy pharma giants like Pfizer and Merck face earnings headwinds from large acquisition-related charges and asset impairments. A wave of aggressive M&A, particularly in biotech (Gilead's $11.2B in acquired IPR&D, Merck's Terns acquisition), is driving significant GAAP losses and depleting cash reserves, signaling a high-stakes bet on pipeline replenishment. Capital allocation patterns are diverging sharply, with Vertex and IDEXX aggressively buying back shares (combined ~$1.5B in H1 2026), while Amgen and Pfizer pause repurchases to fund deals. Insider activity is mixed but notable: Gilead's CEO sold ~$1.96M under a 10b5-1 plan, while Medtronic's top brass received substantial equity awards, suggesting confidence in long-term strategy. The most critical development is the sector-wide margin pressure from rising SG&A (Vertex +37% YoY) and R&D investment, even as top-line growth remains resilient.

30 high priority 6 medium 36 total filings
· daily

S&P 500 Technology Sector SEC Filings — August 03, 2026

The August 3, 2026 SEC filings for the S&P 500 Technology sector reveal a stark divergence between high-growth AI-native companies and mature hardware/software firms. Palantir Technologies reported exceptional Q2 2026 results, with total revenue surging 93% YoY and U.S. commercial revenue skyrocketing 149% YoY, significantly outperforming the sector. The company raised its full-year guidance, signaling sustained momentum. In contrast, KLA Corporation, a semiconductor equipment maker, saw multiple top executives (CEO, CFO, SVP) engage in routine tax-withholding stock sales, indicating no insider conviction but no panic either. Datadog and CrowdStrike saw significant insider selling by directors and CEOs, respectively, under 10b5-1 plans, which may signal profit-taking at elevated valuations. Autodesk completed its acquisition of MaintainX, expanding its asset management capabilities. The overarching theme is a 'two-speed' tech market: AI/software leaders are accelerating, while legacy hardware and cybersecurity firms show insider caution. Portfolio-level trends highlight strong revenue growth in AI-adjacent software, but insider selling patterns suggest skepticism about sustaining current valuations.

12 high priority 1 medium 13 total filings
· daily

Nasdaq 100 Stocks SEC Filings — August 03, 2026

The August 3, 2026 filings for the NASDAQ-100 stream reveal a stark divergence between AI-driven growth and legacy/asset-heavy business models. Palantir's exceptional 93% YoY revenue growth and raised guidance underscore the AI boom, while Strategy Inc's massive unrealized digital asset losses highlight the volatility of crypto-heavy balance sheets. Insider activity is mixed, with a QUALCOMM HR executive selling and Intel insiders engaging in routine transactions. Capital allocation trends show aggressive ATM equity issuance by Strategy Inc to fund Bitcoin purchases and preferred dividends, while Gilead's 13F reveals a concentrated biotech investment portfolio. Sector themes point to AI monetization, crypto volatility, and insider activity patterns. Key catalysts include Palantir's Q3 earnings and continued Bitcoin price sensitivity for Strategy Inc.

5 high priority 3 medium 8 total filings
· daily

S&P 500 Financials Sector SEC Filings — August 03, 2026

The S&P 500 Financials sector is showing a clear divergence between investment banking/trading powerhouses and traditional lenders/insurers. Goldman Sachs reported a stellar quarter with 39% revenue growth and doubling of EPS, driven by a 61% surge in Investment Banking and Market Making, while Progressive Corp faces mounting pressure from a 927% increase in net unrealized losses on its fixed-income portfolio due to rising rates. Insider activity is sending mixed signals: Capital One's President sold $2M in stock under a 10b5-1 plan, while Mitsubishi UFJ reduced its Morgan Stanley stake by $88M. Capital allocation patterns reveal aggressive buyback activity at Goldman Sachs ($9B in H1 2026) and a strategic preferred stock redemption at Northern Trust, signaling confidence in capital positions. The most critical development is the sharp deterioration in fixed-income portfolios across the sector, with Progressive's unrealized losses ballooning to $832M and Goldman Sachs recording a $944M other comprehensive loss, highlighting the impact of the rising rate environment on balance sheets.

5 high priority 2 medium 7 total filings
· daily

S&P 500 Energy Sector SEC Filings — August 03, 2026

The S&P 500 Energy sector is showing a clear bifurcation between upstream/production companies and midstream infrastructure operators. ExxonMobil's Q2 2026 earnings more than doubled YoY to $14.5B, driven by surging revenues and robust cash flow generation, while midstream giants Williams and ONEOK reported solid but more moderate growth, with adjusted EBITDA up 6% and 7% respectively. A significant strategic move is Williams' $5.5B acquisition of Momentum Midstream, signaling consolidation in the Haynesville basin. However, capital spending is surging across the sector—Williams' capex jumped 58% YoY—and cash flow from operations declined at Williams, raising concerns about free cash flow sustainability. Insider activity was concentrated at Kinder Morgan, where the entire C-suite exercised and withheld shares for taxes, a routine but notable event given the simultaneous $1.75B debt issuance. The sector is reinvesting heavily in growth, with shareholder returns (dividends, buybacks) still rising but at a slower pace than capital expenditures.

11 high priority 2 medium 13 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — August 03, 2026

The Consumer Staples sector is showing a clear divergence between defensive growth and inflationary pressure. Clorox's Q4 FY26 earnings reveal significant acquisition-driven revenue growth (GOJO added ~10 points) but severe margin compression (-520 bps gross margin) and declining organic sales, pointing to a challenging operating environment. Insider activity is mixed but notable: Coca-Cola's CFO executed a large $13.3M sale (albeit after a pre-planned option exercise), while Hershey's 10% owner sold ~$1.15M under a 10b5-1 plan, signaling potential caution from key stakeholders. In contrast, Church & Dwight and McCormick are awarding phantom stock to executives, a neutral-to-slightly-bullish retention signal. The sector is experiencing a 'growth through M&A' theme, but the cost of integration and persistent inflation are eroding profitability. The delisting of matured debt for Philip Morris and Procter & Gamble is a non-event, confirming routine capital management. The key takeaway is that while top-line growth is achievable via M&A, organic volume and margin health remain under severe pressure, making stock selection critical.

9 high priority 1 medium 10 total filings
· daily

S&P 500 Industrials Sector SEC Filings — August 03, 2026

The seven filings for August 3, 2026, are exclusively from Honeywell International Inc. and its subsidiary, Honeywell Aerospace Inc., plus one from Republic Services, Inc. The dominant theme is a wave of insider transactions at Honeywell, characterized by the routine exercise and tax-withholding of restricted stock units (RSUs) by senior executives, including the CFO and the President/CEO of a key division. This pattern is typical of scheduled vesting events and does not signal a bearish shift in management sentiment. However, one notable outlier is a direct open-market sale by the President/CEO of Process Technologies, which warrants closer attention for potential conviction change. The Republic Services filing shows a director exercising RSUs, a standard non-cash event. The digest lacks period-over-period financial comparisons, forward-looking guidance, or capital allocation data, limiting the ability to identify broader sector trends. The primary actionable intelligence is the need to monitor Honeywell's upcoming earnings call for commentary on the Process Technologies division and to track any acceleration in insider selling across the broader industrial sector.

7 high priority 7 total filings
· daily

Dow Jones 30 Stocks SEC Filings — August 03, 2026

The August 3, 2026 digest for the Dow Jones 30 reveals a stark divergence between the industrial and financial sectors. Goldman Sachs delivered a standout quarter, with net revenues surging 39% YoY to $20.3B, driven by a 61% jump in Investment Banking and Market Making, while net earnings more than doubled to $6.4B, signaling robust capital markets activity. In contrast, the insider trading patterns across Honeywell International and its subsidiary, Honeywell Aerospace, present a mixed picture: while routine tax-withholding sales by senior executives are neutral, a direct sale by the President/CEO of Process Technologies for $77.6K at a recent high price introduces a bearish signal. The most significant negative signal comes from Coca-Cola, where the President and CFO executed a large, fully disclosed sale of $13.3M in stock after exercising options, a transaction that often raises concerns about valuation or internal outlook. A routine debt delisting for Procter & Gamble is a non-event. The overarching theme is one of financial sector strength versus potential caution signals from industrial and consumer staples leadership, with Goldman Sachs' explosive growth being the dominant, actionable catalyst.

9 high priority 9 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — August 03, 2026

The five filings from the S&P 500 Consumer Discretionary sector reveal a bifurcated landscape. Marriott International's mixed Q2 2026 results show a resilient U.S. market (RevPAR +5.0% YoY) and strong fee growth (+12.8% YoY), but international weakness (RevPAR -0.5%) and a deteriorating balance sheet (stockholders' deficit worsened to -$4.5B) create a cautious outlook. The company raised full-year RevPAR guidance to 3.0-3.5%, signaling confidence in the domestic recovery. Conversely, insider selling at Yum! Brands (CEO and KFC Division CEO sold small tranches under 10b5-1 plans) and a massive $3.54M sale by GM's EVP suggest management is taking profits or hedging exposure. The most critical development is Marriott's record pipeline of ~629,000 rooms and the shift toward conversions (over 40% of openings), which signals a capital-light growth strategy. Portfolio-level patterns show a clear divergence: asset-light, fee-based models (Marriott's franchise fees +18.9% YoY) are outperforming, while legacy auto and restaurant operators face insider skepticism. The key market implication is that investors should favor companies with strong fee income and domestic exposure over those with international headwinds or heavy insider selling.

4 high priority 1 medium 5 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — August 03, 2026

The S&P 500 Healthcare sector shows a clear bifurcation in Q2 2026: large-cap pharma (Pfizer, AbbVie, Eli Lilly) are generating strong revenue growth (7-11% YoY) and margin expansion, while medical device and diagnostics firms (Boston Scientific, Danaher) are navigating margin headwinds from reinvestment and M&A. Insider activity is notably bullish at Boston Scientific, with two separate insider purchases totaling ~$3.2M, signaling strong management conviction. The most critical development is Vertex's $1.65B acquisition of Crinetics, which diversifies its pipeline beyond cystic fibrosis but introduces integration risk. Capital allocation patterns show a shift: AbbVie and Boston Scientific are aggressively returning capital via dividends and buybacks ($8.1B combined in H1 2026), while Gilead maintains a strategic investment portfolio of $1.65B in biotech partnerships. The portfolio-level theme is 'growth through innovation and M&A, funded by strong cash flows, but with rising R&D costs pressuring margins.' Danaher's CEO succession is a key governance event to watch, as it signals a strategic pivot toward diagnostics leadership. Overall, the sector is fundamentally healthy but investors should focus on companies with clear catalysts and disciplined capital allocation, avoiding those with deteriorating balance sheets or integration overhang.

8 high priority 2 medium 10 total filings
· daily

S&P 500 Technology Sector SEC Filings — July 31, 2026

The S&P 500 Technology sector shows a bifurcated landscape this period. Apple Inc. delivered a standout performance with 16% YoY revenue growth and a 27% surge in net income, driven by iPhone, Mac, and Services, while its balance sheet strengthened significantly with a 45.8% increase in shareholders' equity. However, insider activity signals caution: a top executive at Accenture sold $577K under a 10b5-1 plan, and Adobe's SVP & CAO sold shares, suggesting profit-taking or internal caution. Passive institutional ownership remains strong, with Vanguard confirming 7.63% and 5.52% stakes in Marvell Technology and Autodesk, respectively. Qualcomm's filing relates to the Modular Inc. acquisition, a non-operational event. Overall, the sector is characterized by strong operational performance at scale (Apple) but mixed signals from insider transactions, warranting a selective approach. The lack of forward-looking guidance or period-over-period comparisons in most filings limits trend analysis, but Apple's data provides a clear positive anchor.

6 high priority 3 medium 9 total filings
· daily

Nasdaq 100 Stocks SEC Filings — July 31, 2026

The 14 filings from NASDAQ-100 constituents reveal a mixed picture of strong operational performance offset by rising capital intensity and insider caution. Amazon and Apple posted robust revenue growth of 19.6% and 16% YoY respectively, with Apple's net income surging 27% YoY, but Amazon's free cash flow remains negative due to $173B in trailing capex. Linde showed solid 9% sales growth but experienced margin compression across all segments (50-120 bps), while raising full-year EPS guidance to $17.70-$17.90. Insider activity is predominantly negative, with three separate insider sales at ADP, Adobe, and Intuitive Surgical, though two Intuit directors exercised options at $529.97, signaling confidence. The most critical development is Amazon's $90/share acquisition of Globalstar, structured as a tax-free reorganization with regulatory and operational milestones pending. A major cybersecurity incident at Amgen involving exfiltration of proprietary data and patient PHI represents a significant risk. Capital allocation trends show increased share repurchases and dividends at Linde, while Apple's shareholders' equity surged 45.8% as retained earnings turned positive. Overall, the portfolio shows strong top-line growth but faces headwinds from cost inflation, heavy investment cycles, and selective insider selling.

11 high priority 3 medium 14 total filings
· daily

S&P 500 Financials Sector SEC Filings — July 31, 2026

The S&P 500 Financials sector is experiencing a notable bifurcation between strong earnings growth at scale and underlying capital flow challenges. Bank of America and Truist reported double-digit net income growth (26.5% and 25.2% YoY, respectively), driven by robust non-interest income and improved efficiency ratios. However, asset managers like T. Rowe Price confront a significant divergence between record AUM ($1.9T, up 12.9% YoY) and persistent net client outflows ($6.5B in Q2 2026), signaling potential revenue headwinds from fee compression and asset mix shifts. Insider trading activity provides a powerful contrarian signal: a Vice Chair at Visa executed a large $13.6M stock sale following option exercises, while an executive at Marsh & McLennan made a smaller but notable sale. Capital deployment remains aggressive, with T. Rowe Price returning $441M to shareholders and Truist executing substantial buybacks that reduced equity. The Interactive Brokers' shelf takedowns suggest ongoing capital market activity, while weak insider filings (Coinbase) create noise. The key takeaway is that top-line growth is masking idiosyncratic risks in asset management and potential insider sentiment divergence in payments.

5 high priority 4 medium 9 total filings
· daily

S&P 500 Energy Sector SEC Filings — July 31, 2026

The S&P 500 Energy sector is experiencing a powerful earnings boom driven by surging commodity prices, with Brent crude averaging $104/BBL in Q2 2026 versus $68/BBL a year ago. Chevron and ExxonMobil both reported massive year-over-year earnings increases, with Chevron's net income surging from $2.5B to $12.1B and ExxonMobil posting a 247% sequential GAAP earnings jump. However, the picture is nuanced: U.S. natural gas realizations have collapsed to $0.91/MCF from $1.75/MCF, and downstream demand is weakening, with refined product sales falling 13% internationally and 4% in the U.S. Vanguard's passive 13G filings for Devon Energy, SLB, and Valero signal continued institutional confidence in the sector's long-term value, while a small insider purchase at Texas Pacific Land Corp suggests management alignment. The key portfolio-level theme is a tale of two markets: upstream producers are thriving on high oil prices, but downstream and natural gas segments face headwinds from demand destruction and supply disruptions.

1 high priority 5 medium 6 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — July 31, 2026

The S&P 500 Consumer Staples sector is showing a clear bifurcation in Q2 2026: companies with strong brand portfolios and e-commerce capabilities (Church & Dwight, Colgate-Palmolive) are delivering organic growth and margin expansion, while those facing portfolio restructuring or regional weakness are seeing profit compression. Church & Dwight stands out with organic sales growth of 5.8% and a 22.7% surge in global e-commerce, now representing over a quarter of sales, but reported net sales were flat due to strategic portfolio actions. Colgate-Palmolive reported a 4.9% net sales increase with a 140 bps gross margin expansion to 61.5%, yet GAAP EPS fell 5% due to restructuring costs, and North America sales declined 3.0%. Both companies are increasing shareholder returns via dividends and buybacks, signaling management confidence, but rising long-term debt at Colgate ($7.8B vs $6.9B) and a sharp cash decline at Church & Dwight ($254.8M from $409.0M) due to a $300M acquisition warrant caution. The passive 5%+ stakes disclosed by Vanguard in Dollar General and Estee Lauder suggest institutional accumulation in undervalued staples names, but provide no operational signals. The overarching theme is that operational excellence and digital transformation are driving outperformance, while legacy portfolio issues and regional headwinds are creating divergence within the sector.

2 high priority 4 medium 6 total filings
· daily

S&P 500 Industrials Sector SEC Filings — July 31, 2026

The six filings reveal a bifurcated industrial landscape: Eaton Corp's record top-line growth (21% YoY) and raised guidance signal robust demand in electrical markets, but this is overshadowed by a 16.4% GAAP net income decline, 80 bps YoY margin compression, and a massive debt-fueled acquisition spree ($11B in cash for acquisitions, debt up 111% to $18.5B). The Mobility segment's organic sales decline (-2% YoY) and eMobility's -13.7% drop highlight a weak spot, prompting the planned separation via Reverse Morris Trust. Insider selling at ADP ($280K by a Corp VP under a 10b5-1 plan) is a minor negative signal. Meanwhile, Vanguard's 13G filings for Honeywell Aerospace (7.54% stake) and FedEx Freight (5.5% stake) confirm passive institutional accumulation in two newly spun-off or pure-play industrial names, suggesting a sector rotation toward simpler, high-quality assets. The overarching theme is a 'growth vs. quality' trade-off: Eaton is buying growth at the expense of balance sheet strength and margins, while Vanguard's passive bets favor clean, capital-light structures.

3 high priority 3 medium 6 total filings
· daily

Dow Jones 30 Stocks SEC Filings — July 31, 2026

The seven filings from Dow 30 constituents reveal a stark divergence between tech-driven growth and traditional energy volatility. Apple and Amazon posted exceptional revenue and earnings growth, with Apple's net income surging 27% YoY and Amazon's EPS jumping to $5.75 from $1.68, though Amazon's heavy capex ($173B TTM) keeps free cash flow negative. Chevron's earnings skyrocketed to $12.1B from $2.5B on higher oil prices, but its natural gas realizations halved and downstream volumes declined, signaling mixed health. The Amazon-Globalstar S-4 filing introduces a major strategic pivot into satellite communications, with a delayed launch timeline and complex merger terms. A material cybersecurity incident at Amgen and a large insider sale at Visa add risk signals. Vanguard's passive 7.54% stake in Honeywell Aerospace confirms institutional interest in the aerospace spin-off. Period-over-period trends show robust revenue growth across tech (16-20% YoY) but capital allocation diverging sharply—Apple returning cash via buybacks, Amazon investing aggressively, and Chevron benefiting from commodity tailwinds.

5 high priority 2 medium 7 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — July 31, 2026

The six filings reveal a bifurcated Consumer Discretionary landscape. Amazon is executing a transformative satellite acquisition (Globalstar) while reporting a massive Q2 earnings beat, though its cash burn from capex is accelerating. Chipotle shows a classic growth-at-all-costs warning: revenue up 9% YoY but operating income down 6%, with cost inflation and aggressive buybacks eroding retained earnings. General Motors' insider activity (VP tax-withholding sale of $4.36M) is routine, but its 13F signals a deepening vertical integration bet on battery materials and EV charging. eBay's passive stake drop below 5% by Vanguard is a minor sentiment shift. The dominant portfolio-level themes are margin compression despite top-line growth, heavy capital allocation toward strategic M&A and buybacks, and rising leverage across the sector.

4 high priority 2 medium 6 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — July 31, 2026

The S&P 500 Healthcare sector is presenting a mixed picture for Q2 2026, characterized by strong top-line growth at major medical device and diversified pharma companies, contrasted with significant challenges in the biotech and specialty pharma segments. Stryker and Thermo Fisher delivered robust double-digit revenue growth, while AbbVie showed strong core growth driven by immunology and neuroscience, offset by continued Humira erosion. However, Moderna faces a deteriorating cash position and a failed Phase 3 trial, while Amgen disclosed a material cybersecurity breach. A key portfolio-level trend is the aggressive capital deployment for M&A and share buybacks, which is pressuring balance sheets and cash positions across the group. Insider activity was limited but negative at Intuitive Surgical, while forward-looking statements from AbbVie and Moderna point to divergent paths, with AbbVie guiding higher and Moderna struggling to stabilize. The sector is bifurcated between established growth engines and companies facing pipeline or operational headwinds.

5 high priority 2 medium 7 total filings